As the expression and/or activation of TRPM8 suppresses prostate cancer cell migration [69,70,71], TRPM8 was pinpointed as potential molecular target antagonizing metastatic transition of prostate cancer. This evidence concerns the gene TRPM8 and prostate carcinoma.